puc-header

Muscleblind Splicing Factor Regulates Longevity Through p38 MAPK Signaling

36 Pages Posted: 17 Apr 2020 Publication Status: Review Complete

See all articles by Olli Matilainen

Olli Matilainen

University of Helsinki - Institute of Biotechnology

Ana R. S. Ribeiro

University of Helsinki - Institute of Biotechnology

Murat Cetinbas

Harvard University - Massachusetts General Hospital

Ruslan I. Sadreyev

Harvard University - Massachusetts General Hospital

Susana M. D. A. Garcia

University of Helsinki - Institute of Biotechnology

More...

Abstract

Muscleblind-like splicing regulators (MBNLs) are alternative splicing factors that have an important role in developmental processes. Dysfunction of these factors is a key contributor of different neuromuscular degenerative disorders, including Myotonic Dystrophy type 1 (DM1). Since DM1 is a multisystemic disease manifesting in symptoms resembling accelerated aging, we asked whether MBNLs are regulators of longevity. By utilizing the nematode C. elegans, we show that loss of MBL-1 (the sole ortholog of mammalian MBNLs) shortens lifespan by reducing the activity of conserved p38 MAPK signaling as well as the function of transcription factors ATF-7 and SKN-1. Furthermore, we found that modulation of p38 MAPK activity through mitochondrial stress results in significantly stronger lifespan extension in MBL-1-deficient C. elegans compared to wild-type. Together, the data presented here provide a previously unknown mechanism of how a DM1-associated alternative splicing factor regulates aging.

Keywords: Muscleblind-like splicing regulator, MBL-1, p38 MAPK signaling, mitochondrial stress, Aging, C. elegans

Suggested Citation

Matilainen, Olli and Ribeiro, Ana R. S. and Cetinbas, Murat and Sadreyev, Ruslan I. and Garcia, Susana M. D. A., Muscleblind Splicing Factor Regulates Longevity Through p38 MAPK Signaling. Available at SSRN: https://ssrn.com/abstract=3569543 or http://dx.doi.org/10.2139/ssrn.3569543
This version of the paper has not been formally peer reviewed.

Olli Matilainen

University of Helsinki - Institute of Biotechnology

Helsinki, FIN-00014
Finland

Ana R. S. Ribeiro

University of Helsinki - Institute of Biotechnology

Helsinki, FIN-00014
Finland

Murat Cetinbas

Harvard University - Massachusetts General Hospital

MA
United States

Ruslan I. Sadreyev

Harvard University - Massachusetts General Hospital

MA
United States

Susana M. D. A. Garcia (Contact Author)

University of Helsinki - Institute of Biotechnology

Helsinki, FIN-00014
Finland

Click here to go to Cell.com

Paper statistics

Downloads
24
Abstract Views
578
PlumX Metrics